Overall, in this study we have identified a novel interaction between SK2 and the cytoplasmic dynein complex, and we have uncovered a new potential mechanism of SK2 dysregulation in cancer, whereby modulation of IC1 expression in GBM can regulate SK2 subcellular localization and ultimately affect tumorigenic potential. Here, SPHK2 is linked to cancer.